Cipher Pharmaceuticals (OTCMKTS:CPHRF) Shares Cross Above 50-Day Moving Average – Should You Sell?

Cipher Pharmaceuticals Inc. (OTCMKTS:CPHRF) (TSE:CPH)’s stock price passed above its fifty day moving average during trading on Friday . The stock has a fifty day moving average of $8.95 and traded as high as $8.98. Cipher Pharmaceuticals shares last traded at $8.98, with a volume of 4,560 shares.

Cipher Pharmaceuticals Stock Performance

The business’s 50 day simple moving average is $8.95 and its 200 day simple moving average is $9.36.

Cipher Pharmaceuticals Company Profile

Cipher Pharmaceuticals Inc operates as a specialty pharmaceutical company in Canada. It offers Epuris (isotretinoin), an oral retinoid indicated for the treatment of severe nodular and/or inflammatory acne, acne conglobate, and recalcitrant acne; Actikerall, a topical solution indicated for the treatment of slightly palpable and/or moderately thick hyperkeratotic actinic keratosis (Grade I/II) of the face, forehead, and balding scalp; Ozanex for the topical treatment of impetigo; Vaniqa, a topical cream for the slowing of the growth of unwanted facial hair in women; Durela, an opioid analgesic for the management of moderate to moderately severe pain in adults; Brinavess for the rapid conversion of onset atrial fibriallation to sinus rhythm in adults; and Aggrastat, a reversible GP IIb/IIIa inhibitor for use in patients with Acute Coronary Syndrome.